The House Energy and Commerce Subcommittee on Oversight and Investigations today held a hearing to examine the distribution and administration of COVID-19 vaccines. Testifying at the hearing were public health officials from Illinois, Michigan, West Virginia, Louisiana and Colorado.

In a letter Friday to the committee, AHA urged Congress to provide additional funds to the Provider Relief Fund and for vaccine distribution and administration, which will allow continued support for hospitals facing lost revenues related to COVID-19 and additional expenses to purchase supplies and equipment; staff, construct and retrofit facilities; and create emergency testing and vaccination centers.

It also called for stronger federal leadership to resolve vaccine rollout challenges across the states.

“We understand the Administration recently announced a new three-week look-ahead to provide states with more clarity around their allotments,” the letter notes. “This change is an important first step at decreasing uncertainty; however, more must be done through strategic communication and coordination to achieve the vital goal of vaccinating millions of people per day.”

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…